Why is Oxygenta Pharma falling/rising?

As of 30-Jun, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 121.00, reflecting a decrease of 3.0 points or 2.42%. The stock has underperformed its sector by 3.11% today and has been on a downward trend for the last two days, accumulating a total loss of 2.46% during this period. Despite opening with a gain of 4.52% and reaching an intraday high of Rs 129.6, it also touched a low of Rs 117.8, indicating significant volatility. Over the past month, the stock has shown a strong performance with a 27.17% increase, and it has generated impressive returns of 261.30% over the last year. However, the company has a negative book value and weak long-term fundamental strength, which raises concerns among investors, especially as profits have fallen by 184.7% despite the high returns.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has increased by 2.09% over the past week and 2.65% over the past month. While Oxygenta has outperformed the benchmark significantly over the long term, including a 397.94% increase over three years, its short-term performance is lagging behind. The high debt levels and negative EBITDA further contribute to the stock's risk profile, making it less attractive to investors despite its past successes. This combination of factors is likely influencing the current downward movement in the stock price.